Australia markets open in 9 hours 25 minutes

Tonix Pharmaceuticals Holding Corp. (TPM.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.35700.0000 (0.00%)
As of 08:01AM CET. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 21.30M
Enterprise value -112.87M
Trailing P/E 0.30
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.09
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.04

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 3-97.18%
S&P500 52-week change 3-10.86%
52-week high 312.6176
52-week low 30.3490
50-day moving average 30.4830
200-day moving average 32.4194

Share statistics

Avg vol (3-month) 3827
Avg vol (10-day) 32.65k
Shares outstanding 557.54M
Implied shares outstanding 6N/A
Float 857.5M
% held by insiders 10.06%
% held by institutions 110.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:32
Last split date 317 May 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.74%
Return on equity (ttm)-50.14%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -108.4M
Net income avi to common (ttm)-112.35M
Diluted EPS (ttm)-7.1320
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.98M
Total cash per share (mrq)2.43
Total debt (mrq)886k
Total debt/equity (mrq)0.39
Current ratio (mrq)11.33
Book value per share (mrq)4.29

Cash flow statement

Operating cash flow (ttm)-98.2M
Levered free cash flow (ttm)-126.39M